Particle.news
Get it on Google Play
Download on the App Store
4 ARTICLES
·
last mo.

Cohere Buys Reliant AI to Push Into Life Sciences

The move brings domain expertise that can speed Cohere’s push to offer secure AI for tightly regulated health care.

Joelle Pineau, Vice President AI Research, speaks at the at the Meta AI Day in London, Tuesday, April 9, 2024. Meta's prominent executives on the topic of AI discussed the advancements Meta has made in powering innovation, leading cutting-edge research, and developing new tools for creativity and connection. (AP Photo/Kirsty Wigglesworth)
Aidan Gomez of Cohere gives remarks during the All In AI conference in Montreal on Thursday, Sept., 25, 2025. THE CANADIAN PRESS/Christopher Katsarov

Overview

  • Cohere, which announced the deal Tuesday, is acquiring Reliant AI to grow in biopharma and other regulated markets.
  • Reliant builds tools that help drug teams sift medical studies, review clinical trials and rank drug candidates for market fit, with customers like GSK, Ipsen, Kyowa Kirin and OMass.
  • Reliant’s co-founders, Karl Moritz Hermann and Marc Bellemare, will become vice-presidents at Cohere, and about 30 to 35 employees will join the company.
  • Cohere will fold Reliant’s models, data and clients into North, its platform for building task-focused AI agents that companies can run on their own hardware.
  • The purchase lands as Cohere pursues a planned merger with Germany’s Aleph Alpha that still requires approvals, and the Reliant deal’s financial terms were not disclosed.